The Plasma Fractionation Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Plasma Fractionation Market : Drivers and Challenges
The global market for plasma fractionation is expected to be driven by increasing incidences of blood and immune disorders owing to increasing aging population, along with increasing off-label usage of critical plasma products such as albumins, and immunoglobulin’s. According to Centers of Disease Control (CDC), in 2012 chronic diseases were one of the leading causes of death and disability in the U.S., with an estimated 117 Mn adults suffering from some form of chronic disease. Improved diagnostic facilities, and ease of access to healthcare along with increasing incidences and prevalence of chronic diseases around the world, are some factors responsible for the rising demand for plasma derived products and is expected to drive the plasma fractionation market during the forecast period of 2016-2024. However, escalating costs of plasma derivatives and the risk factors associated with them, combined with increasing usage of recombinant proteins and products acting as a substitute for the plasma products are expected to restrain the growth of the global plasma fractionation market during the forecast period of 2016-2024.
Plasma Fractionation Market : Key Players
Some of the key players in global plasma fractionation market include Kedrion S.p.A, CSL Ltd., China Biologic Products, Inc., Baxalta Incorporated, Grifols S.A, Octapharma AG, LFB S.A, Biotest AG, Bio Product Laboratory Ltd., and Sanquin among others.
Plasma Fractionation Market : Regional Overview
Region wise, the global plasma fractionation market is classified into five regions namely, North America, Latin America, Europe, Asia Pacific and Middle East and Africa. North America dominated the global plasma fractionation market in 2015, due to increasing per capita healthcare spending in the U.S., along with rising demand from patients for better and advanced healthcare facilities, and increased adoption of new and advanced technologies. Asia Pacific region is expected to witness highest CAGR in the global plasma fractionation market during the forecast period, due to factors such as increasing prevalence of hemophilia among countries such as China, and India, and increasing aging population in the Asia Pacific region.
Browse Full Report summary and to request sample report and table of content@ http://www.persistencemarketresearch.com/market-research/plasma-fractionation-market.asp